106032-59-1

Basic information

• Product Name: D-MYO-INOSITOL 1-MONOPHOSPHATE CYCLOHEXYLAMMONIUM SALT
• Synonyms: D-MYO-INOSITOL 1-MONOPHOSPHATE CYCLOHEXYLAMMONIUM SALT;D-myo-inositol 1-monophosphate;D-myo-inositol 1-monophosphate bis(cyclo -hexylamine) salt S;D-MYO-INOSITOL 1-MONOPHOSPHATE*CYCLOHEXY LAMMONIUM;D-MYO-INOSITOL 1-MONOPHOSPHATE BIS(CYCL&;D-myo-inositol 1-monophosphate bis(cyclohexylamine) salt;D-myo-Inositol 1-monophosphate bis(cyclohexylammonium) salt;D-myo-Inositol-1-phosphate cyclohexylammonium salt
• CAS NO: 106032-59-1
• Molecular Formula: 2C₆H₁₃N*C₆H₁₃O₉P
• Molecular Weight: 359.31
• Product Categories: Carbohydrates;Carbohydrates A to;Carbohydrates H-LBiochemicals and Reagents;Monosaccharide
• Mol File: 106032-59-1.mol
• Article Data: 8

Chemical Properties

• Flash Point: 14 °C
• Appearance: White to off-white/lyophilized powder
• Storage Temp.: −20°C
• Water Solubility: Soluble in water
• CAS DataBase Reference: D-MYO-INOSITOL 1-MONOPHOSPHATE CYCLOHEXYLAMMONIUM SALT(CAS DataBase Reference)
• NIST Chemistry Reference: D-MYO-INOSITOL 1-MONOPHOSPHATE CYCLOHEXYLAMMONIUM SALT(106032-59-1)
• EPA Substance Registry System: D-MYO-INOSITOL 1-MONOPHOSPHATE CYCLOHEXYLAMMONIUM SALT(106032-59-1)

Safety Data

• Hazard Codes: F,Xi
• Statements: 11-36/37/38
• Safety Statements: 26-36
• RIDADR: UN 1993 3/PG 2
• WGK Germany: 3
• F: 3-10
• Hazardous Substances Data: 106032-59-1(Hazardous Substances Data)

Upstream product

• 6763-49-1 (+/-)-1,2:5,6-dicyclohexylidene-myo-inositol 
• 108-91-8 cyclohexylamine 
• 140391-26-0 1-(1-(S)-camphanyl)-2,3:4,5-dicyclohexylidene-D-myo-inositol 
• 1447463-99-1 (1R,2r,3S,4R,5r,6S)-2,4,5,6-tetrakis((4-methoxybenzyl)oxy)cyclohexane-1,3-diol 
• 1447464-01-8 C₅₆H₅₉N₂O₁₃P 
• 132891-78-2 1,2;4,5-Di-O-cyclohexylidene-3-O-dibenzylphosphoryl-L-myo-inositol 
• 132891-77-1 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-L-myo-inositol 
• 193285-10-8 D-1,2;4,5-di-O-cyclohexylidene-3-((2'S,4'S,5'R)-3',4'-dimethyl-5'-phenyl-1',3',2'-oxazaphospholidin-2'-one)-myo-inositol 
• 193285-11-9 Phosphoric acid (1R,2S)-2-methylamino-1-phenyl-propyl ester (1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentahydroxy-cyclohexyl ester 
• 34361-60-9 1,2:4,5-dicyclohexylidene-myo-inositol 
• 114828-08-9 2,4,6-tri-O-benzyl-myo-inositol 
• 474404-92-7 (+)-2,4,6-tri-O-benzyl-myo-inositol-3-phosphate 
• 2831-74-5 D-myo-inositol-3-phosphate 

Relevant articles and documents

Regioselective phosphorylation of: Myo -inositol with BINOL-derived phosphoramidites and its application for protozoan lysophosphatidylinositol

A regioselective phosphorylation method for myo-inositol was developed by utilizing readily preparable BINOL-derived phosphoramidites. The method also facilitated the complete separation of the diastereomeric products by simple chromatography. Based on this phosphorylation and Ni-catalyzed alkyl-alkyl cross-coupling reaction for long fatty acids, we achieved the first synthesis of a lysophosphatidylinositol, EhPIa having long fatty acid C30:1, as a partial structure of glycosylphosphatidylinositol (GPI) anchor from the cell membrane of a protozoa, Entamoeba histolytica.

Enantiodivergence in small-molecule catalysis of asymmetric phosphorylation: Concise total syntheses of the enantiomeric D-myo-inositol-1-phosphate and D-myo-inositol-3-phosphate

Peptide-based catalysts have been found that catalyze the enantiodivergent phosphorylation of a meso myo-inositol-derived triol (1). The sequential screening of random peptide libraries, followed by the evaluation of a focused library, led to the identifi

Structure of (±)-1,2;4,5-di-o-cyclohexylidene myo-inositol and synthesis of myo-inositol 3-phosphate via its phosphorylation with (2R,4S,5R)-2-chloro-3,4-dimethyl-5-phenyl-1,3,2-oxazaphospholidin-2-one

The crystal structure of (±)-1,2;4,5-di-O-cyclohexylidene myo-inositol, refined to R = 2.9%, shows interestingly disordered (flip-flop) hydrogen bonding. The higher reactivity of the 1/3 positions (rather than 4/6) has been evaluated using semi-empirical calculations. This diol has been phosphorylated with (2R,4S,5R)-2-chloro-3,4-dimethyl-5-phenyl-1,3,2- oxazaphospholidin-2-one and the diastereoisomer derived from phosphorylation at the 3-position was isolated by crystallisation. Deprotection with TFA/H2O then H2/Pd-C afforded myo-inositol 3-phosphate in only four steps from myo- inositol.